WallStreetZenWallStreetZen

NASDAQ: RPTX
Repare Therapeutics Inc Stock Ownership - Who owns Repare Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Repare Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Maria KoehlerEVP CHIEF MEDICAL OFFICER2024-04-01300$4.66
$1.40kSell
Steve ForteEVP CHIEF FINANCIAL OFFICER2024-04-01789$4.61
$3.64kSell
Michael ZindaEVP CHIEF SCIENTIFIC OFFICER2024-04-01410$4.66
$1.91kSell
Lloyd Mitchell SegalPRESIDENT AND CEO2024-04-012,491$4.63
$11.53kSell
Maria KoehlerEVP CHIEF MEDICAL OFFICER2024-03-28500$4.64
$2.32kSell
Lloyd Mitchell SegalPRESIDENT AND CEO2024-03-282,650$4.62
$12.24kSell
Michael ZindaEVP CHIEF SCIENTIFIC OFFICER2024-03-28450$4.64
$2.09kSell
Steve ForteEVP CHIEF FINANCIAL OFFICER2024-03-28825$4.62
$3.81kSell
Steve ForteEVP CHIEF FINANCIAL OFFICER2024-03-27825$4.62
$3.81kSell
Michael ZindaEVP CHIEF SCIENTIFIC OFFICER2024-03-27450$4.62
$2.08kSell

1 of 4

RPTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPTX insiders and whales buy or sell their stock.

RPTX Shareholders

What type of owners hold Repare Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc24.50%10,333,600$33.17MInstitution
Ansbert Gadicke9.20%3,882,485$12.46MInsider
Davis Jerel8.71%3,675,793$11.80MInsider
Versant Vantage I LP8.65%3,650,662$11.72MInsider
Versant Ventures V LLC8.65%3,650,662$11.72MInsider
Orbimed Advisors LLC7.88%3,322,488$10.67MInstitution
Blue Owl Capital Holdings LP7.40%3,122,499$10.02MInstitution
Mpm Bioventures 2014 LP7.12%3,003,772$9.64MInsider
Deep Track Capital LP7.09%2,992,731$9.61MInstitution
Ark Investment Management LLC6.69%2,821,560$9.06MInstitution

1 of 3

RPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPTX61.13%38.87%Net BuyingNet Selling
DBVT39.10%15.37%Net BuyingNet Buying
VTGN38.92%61.08%Net Buying
CTXR16.86%7.74%
SGMT39.98%60.02%Net BuyingNet Buying
View Top Biotech Stocks

Repare Therapeutics Stock Ownership FAQ

Who owns Repare Therapeutics?

Repare Therapeutics (NASDAQ: RPTX) is owned by 86.57% institutional shareholders, 55.03% Repare Therapeutics insiders, and 0.00% retail investors. Ansbert Gadicke is the largest individual Repare Therapeutics shareholder, owning 3.88M shares representing 9.20% of the company. Ansbert Gadicke's Repare Therapeutics shares are currently valued at $11.73M.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.